Published in J Immunol on August 01, 1969
Inhibitory and stimulatory effects of concanavalin A on the response of mouse spleen cell suspensions to antigen. I. Characterization of the inhibitory cell activity. J Exp Med (1972) 3.80
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation. J Exp Med (1986) 2.33
Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med (1973) 2.10
Immunologic rejection of diethylnitrosamine-induced hepatomas in strain 2 guinea pigs: participation of basophilic leukocytes and macrophage aggregates. J Exp Med (1973) 1.18
Lymphotoxin. A review and analysis. Am J Pathol (1976) 1.05
Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man. Clin Exp Immunol (1978) 1.03
Elaboration of lymphotoxin by cultured human peripheral blood leucocytes stimulated with dental-plaque deposits. Clin Exp Immunol (1973) 1.00
On the relation of products of activated lymphocytes to cell-mediated cytolysis. J Exp Med (1974) 0.99
Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction. Proc Natl Acad Sci U S A (1973) 0.98
Mechanisms of lymphocyte-induced cell and tissue destruction in vitro. Am J Pathol (1970) 0.92
Lymphocyte-mediated cytotoxicity in vitro. Effect of enhancing antisera. J Exp Med (1971) 0.91
Effect of soluble products from lectin-stimulated lymphocytes on the growth, adhesiveness, and glycosaminoglycan synthesis of cultured synovial fibroblastic cells. J Clin Invest (1981) 0.90
Regulation of the secondary antibody response in vitro. II. Chemical properties of an antibody inhibitory material (AIM) produced in antigen-stimulated rabbit lymph node organ culture. J Exp Med (1973) 0.89
Immunosuppressive factors released by transforming lymphocytes in the delayed hypersensitivity skin response to tuberculin. Immunology (1973) 0.87
Effect of aprotinin on immunological resistance in tumour-bearing animals. Br J Cancer (1976) 0.86
Stimulation of lymphocyte transformation by autologous serum fractions from patients with rheumatoid arthritis. Immunology (1974) 0.79
Inhibition of the mitogenic response of normal peripheral lymphocytes by extracts or supernatant fluids of a Herpesvirus saimiri lymphoid tumor cell line. Infect Immun (1975) 0.79
I. Evidence that lymphotoxin activity involves both cytotoxic and stimulating factors. Immunology (1976) 0.75
Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell (1990) 5.73
Lymphocyte in vitro cytotoxicity: mechanisms of immune and non-immune small lymphocyte mediated target L cell destruction. J Immunol (1968) 4.66
The hemostatic defect produced by carbenicillin. N Engl J Med (1974) 2.99
Lymphocyte cytotoxicity in vitro: activation and release of a cytotoxic factor. Nature (1968) 2.24
Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis (1982) 2.22
In situ prosthetic graft replacement for mycotic aneurysm of the aorta. Ann Thorac Surg (1989) 2.14
Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol (1987) 2.08
In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes. Antimicrob Agents Chemother (1976) 1.97
Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. Proc Natl Acad Sci U S A (1968) 1.95
Lymphocyte in vitro cytotoxicity: specific release of lymphotoxin-like materials from tuberculin-sensitive lymphoid cells. Nature (1969) 1.94
Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses. Virology (1967) 1.88
Chromatographic alterations in transfer RNA's accompanying speciation, differentiation and tumor formation. J Mol Biol (1968) 1.88
Homograft target cells: contact destruction in vitro by immune macrophages. Science (1966) 1.77
Treatment of postoperative infection of ascending aorta and transverse aortic arch, including use of viable omentum and muscle flaps. Ann Thorac Surg (1990) 1.76
The in vitro induction and release of a cell toxin by immune C57B1-6 mouse peritoneal macrophages. Cell Immunol (1972) 1.73
Gastroenteritis in children: a two-year review in Manitoba. I. Etiology. J Infect Dis (1977) 1.72
Lymphocyte in vitro cytotoxicity: mechanism of lymphotoxin-induced target cell destruction. J Immunol (1969) 1.60
In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin. Antimicrob Agents Chemother (1995) 1.56
Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrob Agents Chemother (1975) 1.49
Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines. J Immunol (1970) 1.43
The human LT system. I. Physical-chemical heterogeneity of LT molecules released by mitogen activated human lymphocytes in vitro. Cell Immunol (1978) 1.40
Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species. Nature (1968) 1.39
Defective platelet function following the administration of penicillin compounds. Blood (1976) 1.37
In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. J Immunol (1983) 1.35
Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci U S A (1990) 1.34
Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (1979) 1.33
Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA (1965) 1.28
Early onset myotonic dystrophy. Clinical and laboratory findings in five families and a review of the literature. Arch Neurol (1967) 1.25
Bioassay for hamycin. Antimicrob Agents Chemother (Bethesda) (1965) 1.24
Relationship of cloning inhibition factor, "lymphotoxin" factor, and proliferation inhibition factor release in vitro by mitogen-activated human lymphoctes. J Immunol (1975) 1.24
Minocycline as an alternative antistaphylococcal agent. Rev Infect Dis (1992) 1.18
In vitro susceptibility of Nocardia to antimicrobial agents. Antimicrob Agents Chemother (Bethesda) (1965) 1.17
Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1. J Natl Cancer Inst (1985) 1.16
Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy. Int J Lepr (1966) 1.15
Similarities and differences among specific tRNA's in mammalian tissues. Proc Natl Acad Sci U S A (1967) 1.15
An improved in vitro assay for lymphotoxin. Cell Immunol (1972) 1.14
Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res (1993) 1.14
Detection of Clostridium difficile toxin in various tissue culture monolayers. J Clin Microbiol (1987) 1.12
Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin. Cell Immunol (1970) 1.12
Phorbol myristate acetate induction of lymphotoxins from continuous human B lymphoid cell lines in vitro. J Biol Response Mod (1984) 1.10
Treatment of mycotic meningitis. Mod Treat (1967) 1.10
Studies on in vitro models of cellular immunity: the role of T and B cells in the secretion of lymphotoxin. Cell Immunol (1973) 1.09
Methicillin-resistant Staphylococcus epidermidis. South Med J (1978) 1.08
Combined effects of ticarcillin and cefazolin on blood coagulation and platelet function. Am J Med Sci (1980) 1.08
Manifestations of sepsis. Arch Intern Med (1987) 1.07
Detection of Clostridium difficile toxin with McCoy cell monolayers and cell suspensions and comparison with HeLa cell assay. J Clin Microbiol (1984) 1.07
Cell-mediated immunity in vitro: a highly sensitive assay for human lymphotoxin. J Immunol (1974) 1.07
Candida osteomyelitis. Report of five cases and review of the literature. Am J Med (1987) 1.06
Synergy of vancomycin plus cefazolin or cephalothin against methicillin-resistance Staphylococcus epidermidis. J Infect Dis (1979) 1.06
Anaerobic bacterial meningitis. Am J Med (1979) 1.05
The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line. J Immunol (1986) 1.05
The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cell Immunol (1991) 1.05
Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agents Chemother (1976) 1.03
The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro. J Immunol (1986) 1.01
Influence of cephalosporin antibiotics on blood coagulation and platelet function. Antimicrob Agents Chemother (1976) 1.00
Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw (1993) 1.00
Vibrio damsela: another potentially virulent marine vibrio. J Infect Dis (1986) 0.99
Purified native and recombinant human alpha lymphotoxin [tumor necrosis factor (TNF)-beta] induces inflammatory reactions in normal skin. J Clin Immunol (1987) 0.98
Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction. Proc Natl Acad Sci U S A (1973) 0.98
Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats. J Immunother (1991) (1991) 0.97
Appearance of ductular hepatocytes in rat liver after bile duct ligation and subsequent zone 3 necrosis by carbon tetrachloride. Am J Pathol (1992) 0.96
Case report. Pseudomonas puncture wound osteomyelitis in adults. Am J Med Sci (1982) 0.95
Development and characterization of a clinically useful animal model of epithelial ovarian cancer in the Fischer 344 rat. Am J Obstet Gynecol (1996) 0.95
Valve replacement in bacterial endocarditis. Chest (1973) 0.95
Agranulocytosis during therapy with orally administered cloxacillin. Am J Clin Pathol (1978) 0.94
Hamycin treatment of experimental blastomycosis in mice. Proc Soc Exp Biol Med (1965) 0.94
Allergic bronchopulmonary aspergillosis-like syndrome consequent to aspergilloma. Am Rev Respir Dis (1979) 0.93
Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis (1980) 0.93
Effect of bacterial endotoxin on experimental fungal infections. J Immunol (1968) 0.93
Regulation of growth of human diploid fibroblasts by factors elaborated by activated lymphoid cells. J Cell Physiol (1982) 0.93
Septicaemia caused by Neisseria flavescens. J Clin Pathol (1968) 0.92
Mechanisms of lymphocyte-induced cell and tissue destruction in vitro. Am J Pathol (1970) 0.92
Surgical considerations of infection following operations involving the descending thoracic aorta. World J Surg (1980) 0.92
Recombinant human alpha lymphotoxin (tumor necrosis factor-beta) induces peripheral neutrophilia and lymphopenia in the rat. Am J Pathol (1987) 0.91
Lymphocyte effector molecules and cell-mediated immune reactions. Contemp Top Mol Immunol (1975) 0.91
Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg (1994) 0.89
Endocarditis after cardiac valvular replacement. Chest (1971) 0.89
Peer review in the 1990s. A look at the Georgia Medical Care Foundation. J Med Assoc Ga (1989) 0.88
Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma. J Interferon Cytokine Res (1995) 0.88
Lymphokines--the mediators of cellular immunity. Ser Haematol (1972) 0.88
Hamycin: chemotherapeutic studies in systemic mycoses of man. Am Rev Respir Dis (1967) 0.88
The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum (1989) 0.88
Candida peritonitis in a quadriplegic: treatment with amphotericin B. South Med J (1972) 0.88
The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte. Cell Immunol (1975) 0.87
Lymphocyte in vitro cytotoxicity: mechanism of human lymphotoxin-induced target cell destruction. Cell Immunol (1973) 0.87
Mechanisms of lymphocyte-mediated cytotoxicity. I. The effects of anti-human lymphotoxin antisera on the cytolysis of allogeneic B cell lines by MLC-sensitized human lymphocytes in vitro. J Immunol (1981) 0.87
Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J Immunol (1993) 0.87
"Contribution to the Question of Pneumotyphus": a discussion of the original article by J. Ritter in 1880. Rev Infect Dis (1985) 0.87
In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro. Cell Immunol (1976) 0.86
Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. J Immunol (1993) 0.86
Serratia marcescens as a postoperative pathogen. Am J Surg (1971) 0.86
Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients. Lymphokine Res (1990) 0.85
Production of lymphotoxin by isolated human tonsillar B lymphocytes and B lymphocyte cell lines. J Clin Invest (1989) 0.85